Key Metabolomics Market Players:
- Thermo Fisher Scientific
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Agilent Technologies
- Bruker Corporation
- Waters Corporation
- SCIEX
- Metabolon
- Biocrates Life Sciences
- LECO Corporation
- Bio-Rad Laboratories
- PerkinElmer
- Sciex (Danaher)
- Phenomenex
- MetaboAnalyst
- BGI Group
- ChromaCell Corporation
- Metabolomic Diagnostics
- Microba Life Sciences
- Xcelris Labs
- Shimadzu Corporation
- Human Metabolome Technologies
- JEOL Ltd.
- Hitachi High-Tech
- Sekisui Medical Co., Ltd.
The metabolomics market features intense competition, where leaders in the U.S., such as Thermo Fisher, Agilent, and Bruker, dominate through advanced MS technology and AI analytics. Employment of cost-effective assets and formation of partnerships are the key strategies of these key players that solidify their leadership in this sector. On the other hand, pioneers in Europe are maintaining their competency via the development of specialized kits, while firms in Asia are more focused on cost-efficient high-throughput solutions.
The cohort of top contenders includes:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In 2026, the industry size of metabolomics is assessed at USD 4.7 billion.
The market size for the metabolomics market is projected to reach USD 15.04 billion by the end of 2035, expanding at a CAGR of 13.8% during the forecast period, i.e., between 2026-2035.
The major players in the market are Thermo Fisher Scientific, Agilent Technologies, Bruker Corporation, Waters Corporation, SCIEX, Metabolon, and others.
The instruments segment is expected to dominate the market with a 32.8% share by the end of 2035.
North America is the dominating region in the metabolomics market and is expected to hold the largest share of 40.5% by 2035.
